← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2008Last known activity
Jun 3, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (12 distinct, 9 trials)
Phase 4 (3 own, 0 via acquisition)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Indications
Recent trials (10)
- NCT07187570Lead sponsorPhase 3Jun 3, 2025
- NCT06941636OfficialPhase 3May 1, 2025
- NCT06941636Lead sponsorPhase 3May 1, 2025
- NCT06140095Lead sponsorEarly Phase 1Feb 29, 2024
- NCT05810311Lead sponsorPhase 2Jan 1, 2024
- NCT06051240Lead sponsorPhase 2Nov 30, 2023
- NCT05679024Lead sponsorPhase 3Feb 17, 2023
- NCT05353829CollaboratorPhase 4Apr 28, 2022
- NCT04910802Sponsor investigatorPhase 4May 3, 2021
- NCT00726960CollaboratorPhase 1Jan 1, 2008
Details
- Last known activity
- Jun 3, 2025